| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 02/02/1994 | EP0581095A2 Substituted acrylic acid esters and plant-protecting agents containing them |
| 02/01/1994 | CA1326669C Herbicidal oxoindanes and tetrahydronaphthalenes |
| 01/26/1994 | EP0580429A1 Use of competitive NMDA receptor antagonists in the treatment of urinary incontinence |
| 01/26/1994 | EP0580402A2 Aminediol protease inhibitors |
| 01/26/1994 | EP0579797A1 Diphosphine ligands |
| 01/26/1994 | EP0408714B1 Heterocyclic sulphonylnitromethanes, process for their preparation and pharmaceutical compositions |
| 01/25/1994 | CA2100950A1 Use of competitive nmda receptor antagonists in the treatment of urinary incontinence |
| 01/25/1994 | CA2100546A1 Substituted acrylates and crop protection agents containing them |
| 01/21/1994 | CA2100894A1 Aminediol protease inhibitors |
| 01/20/1994 | WO1994001408A1 Anilide derivatives |
| 01/19/1994 | CN1080923A Sulfonylbenzyl-substituted benzo-and pyridopyridones |
| 01/18/1994 | US5280032 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| 01/12/1994 | EP0578560A2 Amido-alcohol derivatives as psychotropic agents |
| 01/12/1994 | EP0578163A1 Process for the preparation of D,L or D,L-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid |
| 01/11/1994 | US5278171 Anticholesterol, antilipemic agents |
| 01/11/1994 | US5278169 Administering cromakalim or potassium channel activator |
| 01/09/1994 | CA2100007A1 Preparation of new amido-alcohol derivatives and their therapeutical applications |
| 01/06/1994 | WO1994000435A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | WO1994000122A1 Use of condensed bis-(3,4-dihydro-pyridinyl)methane for treating crohn's disease, colitis ulcerosa, chronic inflamatory processes and as an antiproliferative |
| 01/06/1994 | CA2138788A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions |
| 01/06/1994 | CA2138167A1 Use of condensed bis-(3,4-dihydro-1-pyridinyl)methanes for treating crohn's disease, ulcerative colitis, chronic inflammatory processes and as antiproliferative agents |
| 01/04/1994 | US5276046 Hydrazine derivatives |
| 01/04/1994 | US5276045 Thioformamide derivative, process for its preparation, pharmaceutical composition thereof and treatment method |
| 12/23/1993 | DE4220373A1 New fused ring di:hydro-pyridine-acetic acid derivs. - useful as cardio-protective and cerebro-protective agents, antiinflammatory agents and anticoagulants |
| 12/23/1993 | DE4220369A1 New fused-ring di:hydro-pyridine-acetic acid derivs. - useful as cardio-protective and cerebro-protective agents, antiinflammatory agents and anticoagulants |
| 12/23/1993 | DE4220368A1 New fused-ring di:hydro-pyridine-acetic acid derivs. - useful as cardio-protective and cerebro-protective agents, antiinflammatory agents and anticoagulants or platelet aggregation inhibitors |
| 12/23/1993 | DE4220355A1 New fused di:hydro-pyridine cpds. - useful in treatment of stroke, asthma, arthritis, etc. |
| 12/23/1993 | DE4220353A1 Use of fused di:hydro-pyridinyl phenyl acetic acid derivs. - as anti-proliferative agents in treatment of tumours |
| 12/23/1993 | DE4220345A1 New fused di:hydro:pyridine cpds. - exhibit cardio- and cerebro-protective activity useful in treatment of Crohn's disease, asthma, arthritis, etc. |
| 12/23/1993 | DE4220319A1 New use of fused di:hydro-pyridine(s) - in treatment of ulcerative colitis and Crohn's disease |
| 12/23/1993 | DE4220312A1 New fused ring di:hydro-pyridine derivs. - used e.g. as cardio-protective or cerebral-protective agents, antiinflammatories and blood platelet aggregation inhibitors |
| 12/21/1993 | US5272270 Process for the preparation of 1-alkylisoquinoline derivatives |
| 12/15/1993 | CN1023054C Oxo-1, 2-dihydroindene and tetrahydronaphthalene herbicide |
| 12/09/1993 | WO1993024461A1 Tetrahydro and perhydro isoquinolin derivatives and therapeutic agents containing them |
| 12/09/1993 | CA2136449A1 Tetrahydro- and perhydroisoquinoline derivatives and therapeutic compositions containing these |
| 12/08/1993 | EP0573387A2 Charge-transfer complex with N-aromatic compounds, their preparation and their use |
| 12/08/1993 | CN1079219A Arylacetamides |
| 12/04/1993 | CA2097486A1 Charge-transfer complexes with n-aromatic compounds, the preparation thereof and the use thereof |
| 12/01/1993 | CN1022917C Process for 2-amino-tetrahydro-isoquinoline derivatives |
| 11/30/1993 | US5266700 Bipyridyls and their use as inks |
| 11/30/1993 | US5266576 N-myristoyl transferase inhibitors |
| 11/25/1993 | WO1993023379A1 Retroviral protease inhibitors |
| 11/25/1993 | WO1993023378A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties |
| 11/25/1993 | WO1993023377A1 Process for preparing n-allyl compounds |
| 11/25/1993 | WO1993023357A1 Stilbene derivatives as anticancer agents |
| 11/25/1993 | WO1993020099A3 Cck and/or gastrin receptor ligands |
| 11/25/1993 | DE4216942A1 Tetrahydro- und Perhydroisochinolin-Derivate und diese enthaltende therapeutische Mittel Tetrahydro- and perhydroisoquinoline derivatives and therapeutic agents containing them |
| 11/25/1993 | CA2136312A1 Retroviral protease inhibitors |
| 11/25/1993 | CA2136220A1 Stilbene derivatives as anticancer agents |
| 11/25/1993 | CA2134765A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties |
| 11/25/1993 | CA2118308A1 Process for preparing n-allyl compounds |
| 11/18/1993 | EP0569802A1 Arylacetamides |
| 11/18/1993 | EP0569795A1 Sulphonylbenzyl substituted benzo- and pyridopyridones |
| 11/18/1993 | EP0569794A1 Biphenylmethyl-substituted pyridones useful as angiotensin II receptor antagonists. |
| 11/18/1993 | DE4216314A1 Verfahren zur Herstellung von N-Allylverbindungen A process for the preparation of N-allyl compounds |
| 11/13/1993 | CA2095802A1 Biphenylmethyl-substituted pyridones |
| 11/13/1993 | CA2095801A1 Sulfonylbenzyl-substituted benzo- and pyridopyridones |
| 11/09/1993 | US5260316 Isoquinolyl substituted hydroxylamine derivatives |
| 11/09/1993 | US5260315 Use of dioncophyllines as fungicides |
| 11/02/1993 | US5258520 Process for preparing substituted 2-cyanopyridines |
| 11/02/1993 | US5258065 Ink composition for indicating the progress of sterilization with ethylene oxide |
| 10/28/1993 | WO1993021172A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 10/26/1993 | US5256783 Cyclizing phenethylamine derivatives with formaldehyde in presence of sulfuric acid in acetic acid, cleaving off protecting group |
| 10/26/1993 | US5256677 Enzyme inhibitor for treating acquired immune deficiency syndrome |
| 10/20/1993 | EP0566069A1 Tachykinin receptor antagonists, isoquinolones and their production |
| 10/19/1993 | US5254679 Containing a quaternized nitrogen |
| 10/19/1993 | US5254595 Cardiovascular disorders |
| 10/19/1993 | US5254564 Substituted isoquinoline compounds, pharmaceutical composition and method of use in treating pain in mammals |
| 10/16/1993 | CA2094117A1 Tachykinin receptor antagonists, isoquinolones and their production |
| 10/14/1993 | WO1993020099A2 Cck and/or gastrin receptor ligands |
| 10/12/1993 | US5252738 Process for the preparation of racemic and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and its precursors |
| 10/12/1993 | US5252591 Renin inhibitors |
| 10/06/1993 | EP0563345A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 10/06/1993 | EP0563128A1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines |
| 10/05/1993 | CA1322752C Heteroarylcarboxamide derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 09/30/1993 | WO1993019042A1 Preparation of substituted guanidines |
| 09/30/1993 | CA2130924A1 Preparation of substituted guanidines |
| 09/29/1993 | EP0562049A1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 09/28/1993 | CA1322554C Meta-halo-phenolic alkylation products and epoxy systems |
| 09/21/1993 | US5246950 Thioformamide derivatives |
| 09/21/1993 | US5246943 Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
| 09/14/1993 | US5245034 Compound having vessel smooth muscle relaxation activity |
| 09/14/1993 | US5244904 Immunorepressant, analgesic |
| 09/14/1993 | US5244895 Anti-ulcer agent |
| 09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
| 09/08/1993 | EP0558648A1 Improved matrix metalloprotease inhibitors |
| 09/08/1993 | EP0558630A1 Retroviral protease inhibitors |
| 09/08/1993 | EP0558603A1 Retroviral protease inhibitors |
| 09/07/1993 | US5242892 With 5-aminolevulinic acid |
| 09/02/1993 | WO1993016997A1 2,3,4,5-TETRAHYDRO-1H^_-3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF α-SUBSTITUTED-ARYLACETAMIDES |
| 09/02/1993 | WO1993016986A1 Azo oxime ethers and their use as fungicides |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |
| 09/01/1993 | EP0558392A1 Process for the stabilisation of a charge transfer complex based on 7,7,8,8-tetracyanoquinodimethane |
| 08/31/1993 | US5241065 Selectively antagonize dopamine D-1 receptors |
| 08/31/1993 | US5240950 Carbazate derivatives, their production and use |
| 08/31/1993 | US5240939 Nitrogen bridge tetrahydroisoquinolines |
| 08/24/1993 | US5238955 Anticarcinogenic agents |
| 08/24/1993 | US5238935 Treating atherosclerosis |
| 08/19/1993 | WO1993016050A1 Antipsychotic nitrogen-containing bicyclic compounds |